Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 2 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 2

From: Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer

Fig. 2

a Full-field digital mammography in MLO and CC views and b CESM in MLO and CC views in a 45-year-old woman with pathologically proven invasive duct carcinoma showing a heterogeneously enhancing malignant infiltration with speculated outline occupying the UOQ of the right breast and to a lesser extent to UIQ measuring 11.7 cm in longest diameter. c Follow-up full-field digital mammography in MLO and CC views and CESM in MLO and CC of the right breast after neoadjuvant chemotherapy. The tumor now measures about 8.2 cm in longest diameter indicating a PR with a 30% reduction in tumor size which was confirmed on histopathology examination following a right modified radical mastectomy

Back to article page